Anixa Biosciences Inc Quarterly Debt-to-equity in % from Q1 2015 to Q2 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Anixa Biosciences Inc quarterly Debt-to-equity history and growth rate from Q1 2015 to Q2 2024.
  • Anixa Biosciences Inc Debt-to-equity for the quarter ending July 31, 2024 was 8.38 %, a 25.6% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 8.38 +1.71 +25.6% Jul 31, 2024
Q1 2024 7.84 +1.81 +30% Apr 30, 2024
Q4 2023 7.5 +1.99 +36.1% Jan 31, 2024
Q3 2023 6.92 +1.2 +21% Oct 31, 2023
Q2 2023 6.67 +1.77 +36.1% Jul 31, 2023
Q1 2023 6.02 Apr 30, 2023
Q4 2022 5.51 Jan 31, 2023
Q3 2022 5.72 Oct 31, 2022
Q2 2022 4.9 Jul 31, 2022
Q3 2020 16.7 Oct 31, 2020
Q2 2020 20.2 Jul 31, 2020
Q3 2017 118 -96.2 -45% Oct 31, 2017
Q2 2017 308 +165 +114% Jul 31, 2017
Q1 2017 846 +739 +696% Apr 30, 2017
Q4 2016 1.52K +1.43K +1746% Jan 31, 2017
Q3 2016 214 +147 +217% Oct 31, 2016
Q2 2016 144 +70.7 +96.5% Jul 31, 2016
Q1 2016 106 -35.3 -24.9% Apr 30, 2016
Q4 2015 82.1 Jan 31, 2016
Q3 2015 67.4 Oct 31, 2015
Q2 2015 73.2 Jul 31, 2015
Q1 2015 141 Apr 30, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.